PROSAVIN

Welcome to the Brand page for “PROSAVIN”, which is offered here for Gene therapy products, gene-based medicines and injectable pharmaceuticals for the treatment of neuro-degenerative disorders;enzymes and enzyme preparations for medical purposes, for the treatment of neuro-degenerative disorders; retroviral vector preparations and manufacture of retroviral vector preparations, all for use in gene-based medicines and injectable pharmaceuticals for the treatment of neuro-degenerative disorders; chemical products for in vitro diagnosis for medical use, excluding products for veterinary purposes;instruments and apparatus for the administration of gene therapy, injection devices, syringes, scalpels, catheters and tubes for medical services; surgical and medical apparatus and instruments, injection devices, syringes, scalpels, catheters, tubes for medical services, excluding products for veterinary purposes;.

Its status is currently believed to be active. Its class is unavailable. “PROSAVIN” is believed to be currently owned by “Oxford BioMedica plc”.